Skip to main content
OpenTrials
Recruiting

NCT Number: NCT02959242

Dresden Glaucoma and Treatment Study (DGTS)

To assure the quality of follow-up and treatment, data of glaucoma patients are stored and evaluated after anonymisation.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Glaucoma Eye Diseases Glaucoma, Angle-Closure Glaucoma, Low Tension Glaucoma, Open-Angle Low Tension Glaucoma Ocular Hypertension Optic Nerve Diseases

Sex eligibility

All sexes

Study type

Observational

Primary location

University Eye Hospital, Medical Faculty, Technical University Dresden

Dresden, Saxony, 01307, Germany

Location status: Recruiting

Location contact

Karin R Pillunat, MD

CONTACT

[email protected]

+49 351 458 ext. 3274

Lutz E Pillunat, MD, PhD

CONTACT

[email protected]

+49 351 458 ext. 3381

About this study

The aim of the study is to evaluate the quality of follow-up and treatment by means of consecutive data collection and anonymised analysis of all glaucoma patients of a tertiary university hospital glaucoma service.

Parameters being analyzed are:

Age, sex, refraction, family history, known duration of glaucoma, highest intraocular pressure before treatment, systemic and topical medication, previous ocular surgery.

24h Goldmann-applanation tonometry, biomicroscopy, gonioscopy, Heidelberg Retinal Tomograph (HRT), glaucoma diagnosis with Scanning-Laser-Polarimetry (GDx), optical coherence tomography (OCT), Pentacam, Ocular Response Analyzer (ORA), Corvis ST (Corneal Visualization with the Scheimpflug Technology), perimetry

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • manifest glaucoma, ocular Hypertension, glaucoma suspect

Exclusion criteria

  • under 18 years of age, corneal diseases

Treatment and study plan

Primary outcomes

  1. Follow-up intervals

    Time frame: 20 years

    To find the best follow-up intervals for glaucoma patients.

Secondary outcomes

  1. Assessment of treatment quality

    Time frame: 20 years

    What is the best treatment option for the individual patient?

  2. Assessment of intraocular pressure-lowering efficacy and number of participants with treatment-related adverse events as assessed by CTCAE v4.0 of glaucoma laser therapy

    Time frame: 20 years

    Diurnal intraocular pressure, best corrected visual acuity, visual fields

  3. Assessment of intraocular pressure-lowering efficacy and number of participants with treatment-related adverse events as assessed by CTCAE v4.0 of glaucoma laser therapy of glaucoma surgery

    Time frame: 20 years

    Diurnal intraocular pressure, best corrected visual acuity, visual fields

Study contacts

Contact information is provided by the study sponsor or research team.

Karin R Pillunat, MD

CONTACT

[email protected]

+49 351 458 3274

Lutz E Pillunat, MD, PhD

CONTACT

[email protected]

+49 351 458 3381

Sponsors and collaborators

Lead sponsor

Technische Universität Dresden

Other

Registry information

Official study title

Dresden Glaucoma and Treatment Study: Analysis to Assure the Quality of Follow-up and Therapy of Glaucoma Patients in a Tertiary University Hospital Glaucoma Service.

Important dates

Study start
2006
Primary completion
2030
Study completion
2030
First posted
Nov 9, 2016
Registry last updated
Feb 4, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.